Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New HSL inhibitors claimed

Feb. 24, 2011

Nesina approved in Japan for additional indications in type 2 diabetes

Feb. 24, 2011

Merck & Co. claims new activators of glycoprotein hormone FSH receptor

Feb. 23, 2011

IRM discloses new GPR119 receptor modulators

Feb. 23, 2011

Merck presents new SCD1 inhibitors for metabolic and other disorders

Feb. 22, 2011

Merck Frosst discloses new acyl-CoA desaturase inhibitors

Feb. 22, 2011

Bayer presents new progesterone receptor antagonists

Feb. 22, 2011

FDA requires boxed warning for terbutaline for preterm labor

Feb. 22, 2011

Vitae Pharmaceuticals claims new 11-beta-HSD1 inhibitors

Feb. 21, 2011

Roche patents new activators of glucokinase

Feb. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.